The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis-Reference-Cited by-同舟云学术

The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis

Published:2022-07 Issue: Volume:132 Page:108711
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Gil-Nagel Antonio,Falip Mercè,Sánchez-Carpintero Rocío,Abad-Sazatornil María Reyes,Poveda José Luis,Aibar José Ángel,Cardenal-Muñoz Elena,Aras Luis Miguel,Sánchez Rosa,Sancho-López Arantxa,Trillo-Mata José Luis,Torrejón María,Gil Alicia

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Neurology (clinical),Neurology

Reference66 articles.

1. Child Neurology: Dravet syndrome: when to suspect the diagnosis;Millichap;Neurology,2009

2. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: A population-based study from 2004 to 2009;Bayat;Epilepsia,2015

3. Dravet syndrome: a new causative SCN1A mutation?;Poryo;Clin Case Reports,2017

4. The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome;Aras;Epilepsy Behav,2015

5. Optimizing the diagnosis and management of Dravet Syndrome: RECOMMENDATIONS FROM a North American Consensus Panel;Wirrell;Pediatr Neurol,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD);Orphanet Journal of Rare Diseases;2024-08-23

2. Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: A retrospective and observational real‐world study;Epilepsia Open;2024-08-14

3. Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox–Gastaut syndrome in clinical practice;Epilepsia Open;2024-07-04

4. Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis;Frontiers in Public Health;2024-04-22

5. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA);Epilepsy & Behavior;2023-08